Trial
NCT03515824
Study of MK-1697 in Participants With Advanced Solid Tumors (MK-1697-001)
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Merck Sharp & Dohme LLC
Collaborators
—
Condition
Neoplasms
Intervention
MK-1697
Why stopped
Business Reasons
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-03-09